Although the results from those studies were controversial due to the small sample size and different ethnicities, a recent largest study with 12 international centers reported that the expression of ER or PR is associated with improved survival of subtypes of epithelial ovarian cancer, mainly endometrioid carcinoma and high grade serous carcinoma [22]. This evidence concerns the gene ESR1 and endometrioid adenocarcinoma.